Cervical cancer is the most common gynecological cancer. It is caused by abnormal division and multiplication of cells in the cervix.
It usually occurs around the age of 50, but in recent years its incidence has increased among young women.
It is more common in people who has given birth many times at an early age, had sexual intercourse at an early age, and people who smoke. In addition, HPV infection is a very important risk factor for cervical cancer. HPV infection was detected in 98 % of patients with cervical cancer.
It virtually has no symptoms in the early stages. Problem in the cervix may not be seen during a gynecological examination and with the naked eye. However, it can be detected by a smear test. Final diagnosis can be made by a biopsy of tissue taken from suspected area. The clinical signs of the disease appear if it progresses. Such signs include bloody discharge, bleeding after intercourse, irregular bleeding, lower back and groin pain.
In the early stage, patients can be treated by removing the diseased area of the cervix by a simple operation which takes 5-10 minutes, whereas a larger operation is needed when the disease has progressed. Also radiotherapy may also be required after the operation according to the prevalence of the tumor. In more advanced cases, no surgery can be made. However, radiotherapy and chemotherapy are expected to help. When the disease is detected in the early stage, treatment success rate is 100 percent. This rate is reduced as the disease progresses.
Cervical Cancer Vaccine
Cervical cancer vaccine is a vaccine for protection in general which protects women from cervical cancer and can be applied to people in the age group of 9-26 years. 2 vaccines have been developed against cervical cancer. One of them only protects from the cancer, while the other protects from warts caused by HPV. For this reason, it is ideal to vaccinate 9-12 year old girls.
Whatsapp